Clinical TrialsSearch results
Number of results: 832
Recruiting
- PSMA-DC: An Open-label study comparing lutetium (177Lu) vipivotide tetraxetan (also known as [177Lu]Lu-PSMA-617 or 177Lu-PSMA-617 and hereinafter referred to as AAA617) versus observation in PSMA positive OMPC (CAAA617D12302).
- Oligometastatic Prostate Cancer (OMPC) by PSMA PET, M1 negative by CI.
- Yamauchi Kyosuke
- 2024-01-31
Recruiting
- Survey of self-efficacy as an outcome in rehabilitation
- older people with mild frailty living in the community
- Takahashi Kayoko
- 2021-05-12
Recruiting
- Phase 3 Study to Evaluate the Efficacy and Safety of Orally Administered BF2.649 in Japanese Patients with Obstructive Sleep Apnea Syndrome Complaining Excessive Daytime Sleepiness despite Treated by Nasal Continuous Positive Airway Pressure (nCPAP), Consisting of a Double-blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study (Part 1) and Subsequent Open-label Extension Study (Part 2)
- obstructive sleep apnea syndrome
- Uchimura Naohisa
- 2022-12-09
Other
- Usefulness of oral kanamycin for retrograde infection after biliary stent placement
- Obstructive jaundice
- Gastroenterology Division, Yokohama City University Hospital
- 2009-09-01
Other
- A study to test whether BI 456906 helps people living with overweight or obesity who also have diabetes to lose weight
- Obesity
- Ishibashi Yukiko
- 2024-01-10
Other
- A study to test whether BI 456906 helps people living with overweight or obesity who do not have diabetes to lose weight
- Obesity
- Ishibashi Yukiko
- 2024-01-10
Completed
- A 26-Week, 2-Part Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
- Obesity
- Kawai Norisuke
- 2021-03-14
Recruiting
- A Phase I/II Study of MCLA-128, a full length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients with Solid Tumors (eNRGy)
- NSCLC, pancreatic adenocarcinoma and all other solid tumors with NRG1 fusion
- Wasserman Ernesto
- 2021-12-14
Recruiting
- A Phase III, Randomised, Open-label, Multicentre, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Durvalumab and Carboplatin Versus Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Locally Advanced or Metastatic NSCLC Without Actionable Genomic Alterations (D926NC00001; AVANZAR)
- NSCLC
- Hibi Kazushige
- 2023-02-06
Recruiting
- Pharmacodynamic interaction between remimazolam and remifentanil during anesthesia induction - randomized trial -
- Not limited
- Masui Kenichi
- 2023-08-21